Literature DB >> 34242656

Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Is Associated with Increased Intestinal Inflammation.

Destiny R Matthews1, Honggui Li1, Jing Zhou1, Qingsheng Li2, Shannon Glaser3, Heather Francis4, Gianfranco Alpini4, Chaodong Wu5.   

Abstract

Inflammation drives the pathogenesis of nonalcoholic steatohepatitis (NASH). The current study examined changes in intestinal inflammation during NASH. In male C57BL/6J mice, feeding a methionine- and choline-deficient diet (MCD) resulted in severe hepatic steatosis and inflammation relative to feeding a chow diet (CD). MCD-fed mice exhibited characteristics of mucosal and submucosal inflammatory responses compared with CD-fed mice. Moreover, intestinal phosphorylation states of c-Jun N-terminal protein kinase p46 and mRNA levels of IL-1B, IL-6, tumor necrosis factor alpha, and monocyte chemoattractant protein-1 were significantly higher and intestinal mRNA levels of IL-4 and IL-13 were significantly lower in MCD-fed mice compared with those in CD mice. Surprisingly, upon treatment with MCD-mimicking media, the proinflammatory responses in cultured intestinal epithelial CMT-93 cells did not differ significantly from those in CMT-93 cells treated with control media. In contrast, in RAW264.7 macrophages, MCD-mimicking media significantly increased the phosphorylation states of c-Jun N-terminal protein kinase p46 and mitogen-activated protein kinases p38 and mRNA levels of IL-1B, IL-6, IL-10, and tumor necrosis factor alpha under either basal or lipopolysaccharide-stimulated conditions. Collectively, these results suggest that increased intestinal inflammation is associated with NASH phenotype. Thus, elevated proinflammatory responses in macrophages likely contribute to, in large part, increased intestinal inflammation in NASH.
Copyright © 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34242656      PMCID: PMC8485057          DOI: 10.1016/j.ajpath.2021.06.010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   5.770


  39 in total

1.  Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.

Authors:  Xianjun Luo; Honggui Li; Linqiang Ma; Jing Zhou; Xin Guo; Shih-Lung Woo; Ya Pei; Linda R Knight; Michael Deveau; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Xiangbai Chen; Yuqing Huo; Kelly McDaniel; Heather Francis; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Chaodong Wu
Journal:  Gastroenterology       Date:  2018-09-10       Impact factor: 22.682

2.  STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis.

Authors:  Yongsheng Yu; Yu Liu; Weishuai An; Jingwen Song; Yuefan Zhang; Xianxian Zhao
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

Review 3.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

Review 4.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.

Authors:  Brad Q Starley; Christopher J Calcagno; Stephen A Harrison
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

Review 5.  Human fatty liver disease: old questions and new insights.

Authors:  Jonathan C Cohen; Jay D Horton; Helen H Hobbs
Journal:  Science       Date:  2011-06-24       Impact factor: 47.728

6.  Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice.

Authors:  Xin Guo; Kefeng Xu; Jifeng Zhang; Honggui Li; Weiyu Zhang; Huan Wang; Alex J Lange; Y Eugene Chen; Yuqing Huo; Chaodong Wu
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

7.  NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Authors:  Jorge A Marrero; Robert J Fontana; Grace L Su; Hari S Conjeevaram; Dawn M Emick; Anna S Lok
Journal:  Hepatology       Date:  2002-12       Impact factor: 17.425

8.  Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.

Authors:  Shih-Lung Woo; Hang Xu; Honggui Li; Yan Zhao; Xiang Hu; Jiajia Zhao; Xin Guo; Ting Guo; Rachel Botchlett; Ting Qi; Ya Pei; Juan Zheng; Yiming Xu; Xiaofei An; Lulu Chen; Lili Chen; Qifu Li; Xiaoqiu Xiao; Yuqing Huo; Chaodong Wu
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

9.  Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis.

Authors:  Xiaoyang Zhang; Jun Zhang; Haoran Sun; Xueling Liu; Yue Zheng; Dan Xu; Jianing Wang; Dandan Jia; Xianlin Han; Feng Liu; Jia Nie; Yuguang Shi
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-03-01

10.  Neutrophil infiltration regulates clock-gene expression to organize daily hepatic metabolism.

Authors:  María Crespo; Barbara Gonzalez-Teran; Magdalena Leiva; Ivana Nikolic; Alfonso Mora; Cintia Folgueira; Elena Rodríguez; Luis Leiva-Vega; Aránzazu Pintor-Chocano; Macarena Fernández-Chacón; Irene Ruiz-Garrido; Beatriz Cicuéndez; Antonia Tomás-Loba; Noelia A-Gonzalez; Ainoa Caballero-Molano; Daniel Beiroa; Lourdes Hernández-Cosido; Jorge L Torres; Norman J Kennedy; Roger J Davis; Rui Benedito; Miguel Marcos; Ruben Nogueiras; Andrés Hidalgo; Nuria Matesanz; Guadalupe Sabio
Journal:  Elife       Date:  2020-12-08       Impact factor: 8.140

View more
  1 in total

1.  Saccharomyces Boulardii Ameliorates Non-alcoholic Steatohepatitis in Mice Induced by a Methionine-Choline-Deficient Diet Through Gut-Liver Axis.

Authors:  An-Ming Yang; Chien-Yu Lin; Shih-Hao Liu; Guan-Da Syu; Hao-Jhe Sun; Kuei-Chuan Lee; Han-Chieh Lin; Ming-Chih Hou
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.